MedTrace Logo

DHA Supplementation and Pregnancy Outcome

NCT02219399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 871

Last updated 2014-08-18

No results posted yet for this study

Summary

Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.

Conditions

  • Pregnancy

Interventions

DIETARY_SUPPLEMENT

600 mg DHA

Pregnant women were given 600 mg DHA in the last trimester of pregnancy

DIETARY_SUPPLEMENT

300 mg DHA

Pregnant women were given 300 mg DHA in the last trimester of pregnancy and through the first 3 months of breastfeeding

DIETARY_SUPPLEMENT

Placebo

Pregnant women in the control group received placebo of either olive oil or high oleic acid sunflower oil during the study period

Sponsors & Collaborators

  • USDA Beltsville Human Nutrition Research Center

    collaborator FED

  • Colorado State University

    lead OTHER

Principal Investigators

  • Mary A Harris, PhD · Colorado State University

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2004-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02219399 on ClinicalTrials.gov